Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
31.11
-0.15 (-0.48%)
At close: Feb 13, 2026
41.02% (1Y)
| Market Cap | 1.72B +58.8% |
| Revenue (ttm) | 191.78M -23.0% |
| Net Income | -27.11M |
| EPS | -0.49 |
| Shares Out | 55.19M |
| PE Ratio | n/a |
| Forward PE | 124.44 |
| Dividend | 0.34 (1.09%) |
| Ex-Dividend Date | Oct 24, 2025 |
| Volume | 391,488 |
| Average Volume | 901,663 |
| Open | 31.36 |
| Previous Close | 31.26 |
| Day's Range | 31.03 - 31.64 |
| 52-Week Range | 17.50 - 36.00 |
| Beta | 0.36 |
| RSI | 56.91 |
| Earnings Date | Apr 11, 2026 |